Wos İndeksli Açık & Kapalı Erişimli Yayınlar
Permanent URI for this communityhttps://hdl.handle.net/11727/10751
Browse
3 results
Search Results
Item Endovascular Treatment of Intracranial Aneursyms with Flow Diverter Stents(2020) Igus, Behlul; Selcuk, Hakan; Kara, Batuhan; Firat, Ali; Salik, Aysun Erbahceci; 0000-0003-4874-8141; AAN-1040-2021Objective: We aimed to present the treatment and follow-up results of 41 patients who were treated for intracranial aneurysm with flow diverter stents. Method: Forty-one patients (Age range 27-68 years) were treated with the flow- diverting devices during January 2010 and January 2014. Aneurysms ranged in size from small to large (1-30 mm) and include wide-necked aneurysms, multiple, saccular, blister, dissecan, fusiform and recurrent intracranial aneurysms. Control skull X-Ray Graphy was typically performed at 1, 3 and 6 months after treatment. A follow-up digital subtraction angiogram (DSA) was performed first day, 6 and 12 months after treatment. Conclusions: Complete angiographic occlusion was achieved in 36 patients (88%) at follow-up digital subtraction angiogram. Two transient morbidities and one permanent morbidity occurred due to stent thrombosis. There was no mortality observed. Flow diverter stents are an effective tool in the treatment of large wide neck, high growth rates, and technical problematic aneurysms to treat with conventional endovascular methods.Item Endovascular Recanalization of Thromboangiitis Obliterans (Buerger's Disease) in Twenty-Eight Consecutive Patients and Combined Antegrade-Retrograde Intervention in Eight Patients(2019) Firat, Ali; Igus, Behlul; 0000-0003-3296-7227; 30834476PurposeThe aim of the study was to evaluate the technical success of the procedure and the clinical efficacy of treatment in patients with thromboangiitis obliterans (TAO) (Buerger's disease) based on a change in the Rutherford classification.Materials and MethodsA total of 28 consecutive patients (26 males, 2 females, mean age 43.35.32years) underwent endovascular recanalization with a diagnosis of TAO, between April 2015 and July 2018. After unsuccessful attempts using the antegrade approach, retrograde approaches were used in 8 patients under ultrasound guidance. Clinical follow-up was routinely performed at 1-month, 3-month, 6-month, and 1-year intervals.ResultsA total of 28 TAO patients underwent 40 procedures in 32 limbs. Technical success was achieved in 28 of the 32 limbs (87.5%). In total, 45 of 59 (76.2%) below the knee arteries were treated successfully. One major amputation was performed, providing a 96.8% rate for limb salvage both at 12 and 24months. Amputation-free survival estimated by Kaplan-Meier analysis was 84% at 12 and 24months. Primary patency rates at 12, 24, and 36months were 84%, 78%, and 75%, respectively. Secondary patency rates were 87.5% both at 12 and 24months.Conclusionp id=ParEndovascular treatment is a technically feasible and potentially effective treatment modality for Buerger's disease. Combined antegrade and retrograde interventions in TAO patients may improve technical success and clinical recovery, especially in cases where the antegrade approach has failed.Item Evaluation of Prostatic Artery Embolization Efficiency in Benign Prostatic Hyperplasia Patients with High Comorbidity(2018) Duman, Enes; Yildirim, Ismail Okan; Firat, Ali; Celik, Huseyin; Sarac, KayaObjective: The purpose of this study was to evaluate efficacy outcomes following prostate artery embolization (PAE) for the treatment of benign prostatic hyperplasia (BPH) patients with high comorbidity. Materials and Methods: This retrospective study included 22 patients treated with PAE from May 2015 to June 2017. Patients with Charlson comorbidity index >= 2, International Prostate Symptom Score (IPSS) >12, prostate specific antigen (PSA) levels <4 ng/mL or between 4 and 10 ng/mL with negative prostate biopsy and total prostate volume (TPV) >90 cm(3) were included. Total PSA, maximum flow rate (Q(max)), TPV, IPSS, post-voiding residual (PVR) values were recorded in all patients in the urology clinic before PAE and at 3 and 6 months after PAE. Results: The average patient age was 73.86 +/- 6.25 years and operative time was 80 minutes (range, 60-120 min). Pre-PAE and 6-month post-PAE values were: IPSS: 25.18 +/- 6.75 an d 11.27 +/- 3.29 (p<0.05), Q(max): 8.31 +/- 3.12 and 17.22 +/- 3.23 (p<0.05), PVR: 87.9 +/- 19.25 and 25.86 +/- 7.72 (p<0.05), TPV: 134.45 +/- 57.56 and 86 +/- 15.4 (p<0.05), and PSA: 3.89 +/- 1.26 and 2.11 +/- 1.06 (p<0.05). Embolization was performed unilaterally due to atherosclerosis and strictures in the internal iliac artery branches in 2 patients. After the procedure, 2 patients experienced transient hematuria which did not require bladder irrigation, 1 patient had acute urinary retention due to dysuria, and 1 patient had transient hematospermia. Conclusion: PAE may be an alternative treatment method in BPH patients with high comorbidity.